Vertex Pharmaceuticals has given Mirum Pharmaceuticals the blueprint for success in rare diseases.
Strong demand for GLP-1 drugs and next-gen diagnostic testing is pulling investors back into life sciences, even as AI soaks ...
Southern California has had a flurry of activity—from investments by major companies to acquisitions and an IPO—over the past ...
The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to ...
For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy. According to Eli Casdin, CEO of ...
New Jersey's Johnson & Johnson grew from one ambitious pharmacist to a $94 billion pharmaceutical and medical device giant.
The Fight of Our Lives highlights biotech’s impact on patient lives in both the short- and long-term, urging continued ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...
Smaller acquisitions and disciplined pricing are proving to be big benefits to a wider number of companies ...
Dozens of Massachusetts workers are about to lose their jobs after the FDA rejected a promising cancer drug — for the second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results